Impact of baseline left ventricular volume on left ventricular reverse remodeling after cardiac resynchronization

Xavier Galloo1, Jan Stassen2, Kensuke Hirasawa3

  • 1Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands; Department of Cardiology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

Heart Rhythm
|February 20, 2022
PubMed

Insights

Cardiac resynchronization therapy (CRT) benefits patients with severe left ventricular (LV) dilatation, improving survival. Significant LV reverse remodeling and better outcomes occur regardless of baseline LV volumes.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Left ventricular (LV) dilatation can impede reverse remodeling following cardiac resynchronization therapy (CRT).
  • Understanding the influence of baseline LV volumes is crucial for optimizing CRT outcomes.

Purpose of the Study:

  • To assess the impact of baseline LV volumes on LV reverse remodeling post-CRT.
  • To determine if LV reverse remodeling after CRT is associated with improved long-term survival.

Main Methods:

  • 864 patients were stratified into quintiles based on baseline LV end-diastolic volume indexed for body surface area (LVEDVi).
  • LV reverse remodeling was defined as a ≥15% reduction in LV end-systolic volume at 6-month follow-up.
  • Long-term mortality rates were compared across LVEDVi quintiles and between patients with/without LV reverse remodeling.

Main Results:

  • Patients with larger baseline LVEDVi exhibited worse survival post-CRT.
  • 10-year survival was significantly better in patients achieving LV reverse remodeling (48.7%) versus those who did not (33.9%).
  • Significant LV reverse remodeling occurred across all LVEDVi quintiles, with superior survival observed in remodeling patients irrespective of baseline LV volume.

Conclusions:

  • Significant LV reverse remodeling and superior survival post-CRT are achievable even in patients with severe baseline LV dilatation.
  • Cardiac resynchronization therapy should not be withheld due to severe LV dilatation, as positive remodeling and survival benefits can still be realized.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
87
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
76
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.8K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
70